Micronuclei Enumeration via Dual-Fluorescent Staining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro micronucleus assays face challenges in distinguishing true micronuclei from apoptotic bodies and chromatin of dead and dying cells, limiting their ability to provide accurate and reliable high-throughput genotoxicity testing.
Innovation Solution
A method involving sequential staining with a first fluorescent DNA dye that permeates dead and dying cells and a second dye that stains viable cells, combined with RNase treatment and flow cytometry, allows for differential detection of micronuclei and chromatin from dead and dying cells, enabling accurate enumeration and assessment of genotoxic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional in vitro micronucleus assays are used, then the test can be performed with simple staining procedures, but the ability to distinguish true micronuclei from apoptotic bodies and chromatin of dead and dying cells is poor
Solution Approach 1:
The staining procedure is segmented into multiple sequential steps: first staining with a dye that permeates dead and dying cells, then staining with a second dye that stains viable cells. This segmentation allows differential detection of micronuclei from apoptotic bodies and chromatin of dead and dying cells, resolving the contradiction between measurement precision and procedure complexity.
Solution Approach 2:
The method performs preliminary staining of dead and dying cells with a first fluorescent DNA dye before the secondary staining step. This preliminary action enables subsequent differentiation between true micronuclei and apoptotic bodies based on differential dye uptake, improving measurement precision while maintaining manageable procedure complexity through systematic step-by-step execution.
2Productivity
If in vitro micronucleus assays are used for high-throughput testing, then the throughput capacity increases, but the accuracy of distinguishing true micronuclei from false positives decreases
Solution Approach 1:
The assay is divided into sequential staining steps that can be efficiently automated: first dye permeation into dead and dying cells, then second dye staining of viable cells. This segmentation enables high-throughput processing while maintaining reliability through systematic differentiation of cell states, allowing accurate micronuclei detection at scale.
Solution Approach 2:
The method replaces complex manual differentiation techniques with a systematic dual-dye staining approach that can be automated using flow cytometry or automated image analysis. This substitution enables high-throughput processing while maintaining high reliability through objective, quantifiable differentiation between true micronuclei and false positives based on differential fluorescent signal patterns.
3Ease of operation
If simple staining methods are used, then the ease of operation improves, but the reliability of genotoxicity assessment deteriorates
Solution Approach 1:
The staining procedure is segmented into two distinct steps: first staining with a dye that permeates dead and dying cells, then second staining with a dye that stains viable cells. This segmentation maintains ease of operation through clear, sequential instructions while significantly improving reliability of genotoxicity assessment by enabling accurate differentiation between true micronuclei and artifacts.
Solution Approach 2:
The method utilizes differential fluorescent staining patterns as visual and quantifiable color changes to distinguish between cell states. The first dye produces a specific fluorescent signal in dead and dying cells, while the second dye produces a different signal pattern in viable cells. This color differentiation maintains operational simplicity while dramatically improving the reliability of genotoxicity assessment through objective, visually distinguishable criteria.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a robust, reliable, and high-throughput method for enumerating micronuclei, enhancing the accuracy and reliability of genotoxicity testing, reducing the need for animal testing and offering significant cost savings.
Implementation Method 1
contacting a sample containing mammalian cells with a first fluorescent DNA dye that permeates dead and dying cells but not viable cells
Implementation Method 2
The free nuclei and/or micronuclei are contacted with RNase to substantially degrade RNA
Implementation Method 3
Cellular DNA is stained with a second fluorescent DNA dye having a fluorescent emission spectrum which does not substantially overlap with the fluorescent emission spectrum of the first fluorescent DNA dye
Data Source
AI summary
The present invention relates a method for the enumeration of mammalian cell micronuclei, while distinguishing micronuclei from the chromatin of dead and dying cells. The method utilizes differential staining of chromatin from dead and dying cells, to distinguish the chromatin from micronuclei and nuclei that can be detected based upon fluorescent emission and light scatter following exposure to an excitatory light source. Counting of micronuclei events relative to the number of nuclei can be used to assess the DNA-damaging potential of a chemical agent, the DNA-damaging potential of a physical agent, the effects of an agent which can modify endogenously-induced DNA damage, and the effects of an agent which can modify exogenously-induced DNA damage. Kits for practicing the invention are also disclosed.